APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over the Counter (OTC) Drugs & Dietary Supplements

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Outlook and Growth Opportunities 2026

20 December 2025205 pages

Choose your research edition.

Industry ResearchOver the Counter (OTC) Drugs & Dietary Supplements Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Over the Counter (OTC) Drugs & Dietary Supplements Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Over the Counter (OTC) Drugs & Dietary Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Over the Counter (OTC) Drugs & Dietary Supplements market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Over the Counter (OTC) Drugs & Dietary Supplements market include Sanofi S.A, Johnson & Johnson, Novartis International AG, Merck & Co., Inc., Roche Holding AG, Pfizer Inc., GlaxoSmithKline plc., Bayer Healthcare AG and AbbVie Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Over the Counter (OTC) Drugs & Dietary Supplements market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Over the Counter (OTC) Drugs & Dietary Supplements and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Over the Counter (OTC) Drugs & Dietary Supplements revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Over the Counter (OTC) Drugs & Dietary Supplements market.

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Company

Sanofi S.A

Johnson & Johnson

Novartis International AG

Merck & Co., Inc.

Roche Holding AG

Pfizer Inc.

GlaxoSmithKline plc.

Bayer Healthcare AG

AbbVie Inc.

AstraZeneca plc.

The Colgate-Palmolive Company

Reckitt Benckiser Plc.

Gilead Sciences

Bausch & Lomb

Alliance Healthcare

Allergan, Plc.

Alkalon A/S

Alfresa Pharma Corporation

Alcon Inc.

Alacer Corp.

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Type

Cough, Cold, and Flu Products

Mineral Supplements

Dermatological Products

Vitamin Supplements

Ophthalmic Products

Analgesic & Pain Relievers

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Application

Retail Pharmacies

Online Pharmacy

Hospital Pharmacies

Others

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Over the Counter (OTC) Drugs & Dietary Supplements status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Over the Counter (OTC) Drugs & Dietary Supplements key companies, revenue, market share, and recent developments.

3. To split the Over the Counter (OTC) Drugs & Dietary Supplements breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Over the Counter (OTC) Drugs & Dietary Supplements market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Over the Counter (OTC) Drugs & Dietary Supplements significant trends, drivers, influence factors in global and regions.

6. To analyze Over the Counter (OTC) Drugs & Dietary Supplements competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Drugs & Dietary Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Drugs & Dietary Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Drugs & Dietary Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Over the Counter (OTC) Drugs & Dietary Supplements industry.

Chapter 3: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Over the Counter (OTC) Drugs & Dietary Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Over the Counter (OTC) Drugs & Dietary Supplements in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends Table 2. Over the Counter (OTC) Drugs & Dietary Supplements Industry Drivers Table 3. Over the Counter (OTC) Drugs & Dietary Supplements Industry Opportunities and Challenges Table 4. Over the Counter (OTC) Drugs & Dietary Supplements Industry Restraints Table 5. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Company (2021-2026) Table 7. Global Over the Counter (OTC) Drugs & Dietary Supplements Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Key Company Manufacturing Base & Headquarters Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Company, Product Type & Application Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cough, Cold, and Flu Products Table 15. Significant Companies of Mineral Supplements Table 16. Significant Companies of Dermatological Products Table 17. Significant Companies of Vitamin Supplements Table 18. Significant Companies of Ophthalmic Products Table 19. Significant Companies of Analgesic & Pain Relievers Table 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type (2021-2026) Table 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Retail Pharmacies Table 26. Significant Companies of Online Pharmacy Table 27. Significant Companies of Hospital Pharmacies Table 28. Significant Companies of Others Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application (2021-2026) Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application (2027-2032) Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Region (2021-2026) Table 37. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Region (2027-2032) Table 39. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Market Share by Country (2021-2026) Table 42. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Market Share by Country (2027-2032) Table 44. Sanofi S.A Company Information Table 45. Sanofi S.A Business Overview Table 46. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 48. Sanofi S.A Recent Development Table 49. Johnson & Johnson Company Information Table 50. Johnson & Johnson Business Overview Table 51. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 53. Johnson & Johnson Recent Development Table 54. Novartis International AG Company Information Table 55. Novartis International AG Business Overview Table 56. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 58. Novartis International AG Recent Development Table 59. Merck & Co., Inc. Company Information Table 60. Merck & Co., Inc. Business Overview Table 61. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 63. Merck & Co., Inc. Recent Development Table 64. Roche Holding AG Company Information Table 65. Roche Holding AG Business Overview Table 66. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 68. Roche Holding AG Recent Development Table 69. Pfizer Inc. Company Information Table 70. Pfizer Inc. Business Overview Table 71. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 73. Pfizer Inc. Recent Development Table 74. GlaxoSmithKline plc. Company Information Table 75. GlaxoSmithKline plc. Business Overview Table 76. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 78. GlaxoSmithKline plc. Recent Development Table 79. Bayer Healthcare AG Company Information Table 80. Bayer Healthcare AG Business Overview Table 81. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 83. Bayer Healthcare AG Recent Development Table 84. AbbVie Inc. Company Information Table 85. AbbVie Inc. Business Overview Table 86. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 88. AbbVie Inc. Recent Development Table 89. AstraZeneca plc. Company Information Table 90. AstraZeneca plc. Business Overview Table 91. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 93. AstraZeneca plc. Recent Development Table 94. The Colgate-Palmolive Company Company Information Table 95. The Colgate-Palmolive Company Business Overview Table 96. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 98. The Colgate-Palmolive Company Recent Development Table 99. Reckitt Benckiser Plc. Company Information Table 100. Reckitt Benckiser Plc. Business Overview Table 101. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 103. Reckitt Benckiser Plc. Recent Development Table 104. Gilead Sciences Company Information Table 105. Gilead Sciences Business Overview Table 106. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 108. Gilead Sciences Recent Development Table 109. Bausch & Lomb Company Information Table 110. Bausch & Lomb Business Overview Table 111. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 113. Bausch & Lomb Recent Development Table 114. Alliance Healthcare Company Information Table 115. Alliance Healthcare Business Overview Table 116. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 118. Alliance Healthcare Recent Development Table 119. Allergan, Plc. Company Information Table 120. Allergan, Plc. Business Overview Table 121. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 123. Allergan, Plc. Recent Development Table 124. Alkalon A/S Company Information Table 125. Alkalon A/S Business Overview Table 126. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 128. Alkalon A/S Recent Development Table 129. Alfresa Pharma Corporation Company Information Table 130. Alfresa Pharma Corporation Business Overview Table 131. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 133. Alfresa Pharma Corporation Recent Development Table 134. Alcon Inc. Company Information Table 135. Alcon Inc. Business Overview Table 136. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 138. Alcon Inc. Recent Development Table 139. Alacer Corp. Company Information Table 140. Alacer Corp. Business Overview Table 141. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 143. Alacer Corp. Recent Development Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Product Image Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Over the Counter (OTC) Drugs & Dietary Supplements Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cough, Cold, and Flu Products Image Figure 8. Mineral Supplements Image Figure 9. Dermatological Products Image Figure 10. Vitamin Supplements Image Figure 11. Ophthalmic Products Image Figure 12. Analgesic & Pain Relievers Image Figure 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type (2021-2032) Figure 16. Retail Pharmacies Image Figure 17. Online Pharmacy Image Figure 18. Hospital Pharmacies Image Figure 19. Others Image Figure 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application (2021-2032) Figure 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032) & (US$ Million) Figure 26. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032) & (US$ Million) Figure 32. South America Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Cough, Cold, and Flu Products
  • Mineral Supplements
  • Dermatological Products
  • Vitamin Supplements
  • Ophthalmic Products
  • Analgesic & Pain Relievers
Applications
  • Retail Pharmacies
  • Online Pharmacy
  • Hospital Pharmacies
  • Others
Companies covered
  • Sanofi S.A
  • Johnson & Johnson
  • Novartis International AG
  • Merck & Co., Inc.
  • Roche Holding AG
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Bayer Healthcare AG
  • AbbVie Inc.
  • AstraZeneca plc.
  • The Colgate-Palmolive Company
  • Reckitt Benckiser Plc.
  • Gilead Sciences
  • Bausch & Lomb
  • Alliance Healthcare
  • Allergan, Plc.
  • Alkalon A/S
  • Alfresa Pharma Corporation
  • Alcon Inc.
  • Alacer Corp.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
  1. 2.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
  2. 2.2 Over the Counter (OTC) Drugs & Dietary Supplements Industry Drivers
  3. 2.3 Over the Counter (OTC) Drugs & Dietary Supplements Industry Opportunities and Challenges
  4. 2.4 Over the Counter (OTC) Drugs & Dietary Supplements Industry Restraints
3 Over the Counter (OTC) Drugs & Dietary Supplements Market by Company
  1. 3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Company Revenue Ranking in 2025
  2. 3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (2021-2026)
  3. 3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Company Ranking (2024-2026)
  4. 3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Company Manufacturing Base and Headquarters
  5. 3.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Company Product Type and Application
  6. 3.6 Global Over the Counter (OTC) Drugs & Dietary Supplements Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Over the Counter (OTC) Drugs & Dietary Supplements Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Over the Counter (OTC) Drugs & Dietary Supplements Market by Type
  1. 4.1 Over the Counter (OTC) Drugs & Dietary Supplements Type Introduction
  2. 4.1.1 Cough, Cold, and Flu Products
  3. 4.1.2 Mineral Supplements
  4. 4.1.3 Dermatological Products
  5. 4.1.4 Vitamin Supplements
  6. 4.1.5 Ophthalmic Products
  7. 4.1.6 Analgesic & Pain Relievers
  8. 4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Type
  9. 4.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Type (2021-2032)
  11. 4.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type (2021-2032)
5 Over the Counter (OTC) Drugs & Dietary Supplements Market by Application
  1. 5.1 Over the Counter (OTC) Drugs & Dietary Supplements Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Application
  7. 5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Application (2021-2032)
  9. 5.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application (2021-2032)
6 Over the Counter (OTC) Drugs & Dietary Supplements Regional Value Analysis
  1. 6.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Region (2021-2032)
  3. 6.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Region: 2021-2026
  4. 6.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032)
  7. 6.3.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032)
  10. 6.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032)
  16. 6.6.2 South America Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Country, 2025 VS 2032
7 Over the Counter (OTC) Drugs & Dietary Supplements Country-level Value Analysis
  1. 7.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Country (2021-2032)
  3. 7.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Country (2021-2026)
  4. 7.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Over the Counter (OTC) Drugs & Dietary Supplements Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi S.A
  2. 8.1.1 Sanofi S.A Company Information
  3. 8.1.2 Sanofi S.A Business Overview
  4. 8.1.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  6. 8.1.5 Sanofi S.A Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis International AG
  14. 8.3.1 Novartis International AG Company Information
  15. 8.3.2 Novartis International AG Business Overview
  16. 8.3.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  18. 8.3.5 Novartis International AG Recent Developments
  19. 8.4 Merck & Co., Inc.
  20. 8.4.1 Merck & Co., Inc. Company Information
  21. 8.4.2 Merck & Co., Inc. Business Overview
  22. 8.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  24. 8.4.5 Merck & Co., Inc. Recent Developments
  25. 8.5 Roche Holding AG
  26. 8.5.1 Roche Holding AG Company Information
  27. 8.5.2 Roche Holding AG Business Overview
  28. 8.5.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  30. 8.5.5 Roche Holding AG Recent Developments
  31. 8.6 Pfizer Inc.
  32. 8.6.1 Pfizer Inc. Company Information
  33. 8.6.2 Pfizer Inc. Business Overview
  34. 8.6.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  36. 8.6.5 Pfizer Inc. Recent Developments
  37. 8.7 GlaxoSmithKline plc.
  38. 8.7.1 GlaxoSmithKline plc. Company Information
  39. 8.7.2 GlaxoSmithKline plc. Business Overview
  40. 8.7.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  42. 8.7.5 GlaxoSmithKline plc. Recent Developments
  43. 8.8 Bayer Healthcare AG
  44. 8.8.1 Bayer Healthcare AG Company Information
  45. 8.8.2 Bayer Healthcare AG Business Overview
  46. 8.8.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  48. 8.8.5 Bayer Healthcare AG Recent Developments
  49. 8.9 AbbVie Inc.
  50. 8.9.1 AbbVie Inc. Company Information
  51. 8.9.2 AbbVie Inc. Business Overview
  52. 8.9.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  54. 8.9.5 AbbVie Inc. Recent Developments
  55. 8.10 AstraZeneca plc.
  56. 8.10.1 AstraZeneca plc. Company Information
  57. 8.10.2 AstraZeneca plc. Business Overview
  58. 8.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  60. 8.10.5 AstraZeneca plc. Recent Developments
  61. 8.11 The Colgate-Palmolive Company
  62. 8.11.1 The Colgate-Palmolive Company Company Information
  63. 8.11.2 The Colgate-Palmolive Company Business Overview
  64. 8.11.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  65. 8.11.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  66. 8.11.5 The Colgate-Palmolive Company Recent Developments
  67. 8.12 Reckitt Benckiser Plc.
  68. 8.12.1 Reckitt Benckiser Plc. Company Information
  69. 8.12.2 Reckitt Benckiser Plc. Business Overview
  70. 8.12.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  72. 8.12.5 Reckitt Benckiser Plc. Recent Developments
  73. 8.13 Gilead Sciences
  74. 8.13.1 Gilead Sciences Company Information
  75. 8.13.2 Gilead Sciences Business Overview
  76. 8.13.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  78. 8.13.5 Gilead Sciences Recent Developments
  79. 8.14 Bausch & Lomb
  80. 8.14.1 Bausch & Lomb Company Information
  81. 8.14.2 Bausch & Lomb Business Overview
  82. 8.14.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  84. 8.14.5 Bausch & Lomb Recent Developments
  85. 8.15 Alliance Healthcare
  86. 8.15.1 Alliance Healthcare Company Information
  87. 8.15.2 Alliance Healthcare Business Overview
  88. 8.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  90. 8.15.5 Alliance Healthcare Recent Developments
  91. 8.16 Allergan, Plc.
  92. 8.16.1 Allergan, Plc. Company Information
  93. 8.16.2 Allergan, Plc. Business Overview
  94. 8.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  96. 8.16.5 Allergan, Plc. Recent Developments
  97. 8.17 Alkalon A/S
  98. 8.17.1 Alkalon A/S Company Information
  99. 8.17.2 Alkalon A/S Business Overview
  100. 8.17.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  102. 8.17.5 Alkalon A/S Recent Developments
  103. 8.18 Alfresa Pharma Corporation
  104. 8.18.1 Alfresa Pharma Corporation Company Information
  105. 8.18.2 Alfresa Pharma Corporation Business Overview
  106. 8.18.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  108. 8.18.5 Alfresa Pharma Corporation Recent Developments
  109. 8.19 Alcon Inc.
  110. 8.19.1 Alcon Inc. Company Information
  111. 8.19.2 Alcon Inc. Business Overview
  112. 8.19.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  114. 8.19.5 Alcon Inc. Recent Developments
  115. 8.20 Alacer Corp.
  116. 8.20.1 Alacer Corp. Company Information
  117. 8.20.2 Alacer Corp. Business Overview
  118. 8.20.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  120. 8.20.5 Alacer Corp. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst